SB 917 – Mandates insurance coverage for new phases of clinical trials undertaken for the treatment of cancer

• Sponsor: Dougherty
• LR Number: 2779S.01I
• Committee: Small Business, Insurance & Industrial Relations
• Last Action: 1/15/2004 - Second Read and Referred S Small Business, Insurance and Industrial Relations Committee
• Journal Page: S117
• Effective Date: August 28, 2004

Current Bill Summary

SB 917 - This act requires health insurance companies to provide coverage for routine patient care costs incurred as the result of phase I or II clinical trials undertaken to treat cancer. Currently, Section 376.429, RSMo, requires coverage for phases III or IV only.

LORIE TOWE

Amendments

No Amendments Found.